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Ectopic lymphoid follicles are hallmarks of chronic
autoimmune inflammatory diseases such as multiple
sclerosis (MS), rheumatoid arthritis, Sjo¨gren’s syn-
drome, andmyasthenia gravis. However, the effector
cells and mechanisms that induce their development
are unknown. Here we showed that in experimental
autoimmune encephalomyelitis (EAE), the animal
model of MS, Th17 cells specifically induced ectopic
lymphoid follicles in the central nervous system
(CNS). Development of ectopic lymphoid follicles
was partly dependent on the cytokine interleukin 17
(IL-17) and on the cell surface molecule Podoplanin
(Pdp), which was expressed on Th17 cells, but
not on other effector T cell subsets. Pdp was also
crucial for the development of secondary lymphoid
structures: Pdp-deficient mice lacked peripheral
lymph nodes and had a defect in forming normal
lymphoid follicles and germinal centers in spleen
and lymph node remnants. Thus, Th17 cells are
uniquely endowed to induce tissue inflammation,
characterized by ectopic lymphoid follicles within
the target organ.
INTRODUCTION
In multiple sclerosis (MS), lymphoid follicle-like structures are
observed in close association with inflamed blood vessels in
leptomeninges of patients with chronic progressive but not
relapsing-remitting disease. These follicle-like structures appear
to be in different stages of development, ranging from simple T
and B cell clusters to well-organized follicles, encapsulated by
reticulin lining, which contain T cells, proliferating B cells, plasma
cells, and follicular dendritic cells, suggestive of germinal centers
(GCs) (Magliozzi et al., 2007; Serafini et al., 2004). However, not
all the features and definable markers of a secondary lymphoid
follicle with discernable T and B cell zones and well-developed
GCs are always observed in ectopic lymphoid follicle-like struc-986 Immunity 35, 986–996, December 23, 2011 ª2011 Elsevier Inc.tures (eLFs) in the target organ in an autoimmune disease
(Weyand et al., 2001). eLFs are able to drive chronic inflamma-
tion directly in the target organ, accelerate and/or maintain the
disease process, and are often considered a hallmark of an
aggressive chronic disease course (Weyand et al., 2001). We
have previously shown that myelin oligodendrocyte glycoprotein
(MOG)-specific 2D2 T cell receptor (TCR) transgenic T helper 1
(Th1) and Th17 cells can induce experimental autoimmune
encephalomyelitis (EAE) with similar severity upon adoptive
transfer into wild-type (WT) recipient mice (Ja¨ger et al., 2009).
Importantly, histological analysis of the central nervous system
(CNS) revealed important differences between the CNS lesions
of Th1 and Th17 cell recipients: the infiltrating cells in the CNS
of Th17 cell recipients aggregated into relatively large organized
structures reminiscent of eLFs, suggesting that Th17 cells may
be able to induce eLF-like structures in the CNS. In this study,
we show that Th17 cells are uniquely endowed to induce eLFs
in the target tissue and that the signature cytokine interleukin
17 (IL-17) and the cell surface molecule Podoplanin (Pdp), which
is expressed on Th17 cells, contribute to the development of
eLFs.RESULTS
Th17 Cell Recipients Form Ectopic Lymphoid Follicles
in the CNS
After transfer of MOG-specific Th17 cells, CNS-infiltrating cells
formed organized lymphoid aggregates in the subarachnoid
space that were often located around or near blood vessels
and surrounded by reticulin fibers (Figure 1A). Reticulin fibers
are mainly composed of type III collagen, a structural molecule
produced by stromal cells. In lymph nodes (LNs), collagen-posi-
tive fibers form networks and conduits that organize the follicles
(Roozendaal et al., 2009). Immunohistochemical analysis re-
vealed that the organized follicle-like structures in the CNS of
Th17 cell recipients were composed of B cell clusters, sur-
rounded by T cells and encapsulated by collagen fibers (Figures
1B and 1C). The fibers even extended into the center of B cell
clusters, reminiscent of the collagen-lined conduits described
in LN follicles (Roozendaal et al., 2009). Overall, the aggregates
had variable degrees of organization and maturation; in some
Figure 1. Recipients of MOG-Specific Th17 Cells Develop Ectopic Lymphoid Follicle-like Structures in the CNS
(A) Hematoxylin and eosin staining of a paraffin section of the anterior spinal cord of a Th17 cell recipient shows the anterior spinal columns (left and right upper
corners of the field) with large aggregates of dark-blue lymphocytes within the subarachnoid space surrounding the anterior spinal artery (arrow) (left). Silver stain
for reticulin reveals dark brown fibers indicating structural organization of the follicle (right, arrowheads). Note that the concentric pattern of reticulin surrounding
the artery in the subarachnoid space differs from the smaller branching pattern of capillaries in the parenchyma.
(B) Cryosection of the CNS stained for B cells (B220, blue), T cells (CD4, green), and collagen (red).
Scale bars represent 50 mm.
(C) Staining for T cells (CD3, green), B cells (B220, blue), and collagen (red) shows several large B cell clusters surrounded by T cells and collagen-positive fibers in
the subarachnoid space. Scale bar represents 100 mm.
All pictures are representative of three or more independent experiments.
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Th17 Cells Induce Ectopic Lymphoid Folliclesinstances theymarkedly expanded the spinal cord subarachnoid
space and extended over long areas in longitudinal sections (Fig-
ure 1C). Analysis of the infiltrates by flow cytometry confirmed
the presence of both T and B cells in the CNS of Th17 cell recip-
ients (Figure 2A). The majority of T cells (>80%) present in the
CNS were transferred Th17 cells, as shown by the fact that
they expressed the transgenic TCR chain Va3.2 (Figure 2B).
Notably, among both CNS-derived T and B cells, we detected
expression of the GCmarker GL7 (Figure 2C), as well as expres-
sion of another GC-marker PNA (Figure S1A available online),
indicating that at least some of the CNS B and T cells exhibitIfeatures of cells undergoing a GC reaction in the eLF. Accord-
ingly, 4%–7% of the CNS B cells were negative for IgD and
IgM but positive for IgG and had thus undergone isotype
switching (Figure S1B). In addition to regular B cells, we also
found some CD138+CD11b plasma cells in the CNS (Fig-
ure S2A). T cells isolated from the CNS expressed CCR6, a che-
mokine receptor specifically expressed on Th17 cells, but we
also observed expression of CXCR5, ICOS, and Bcl6 (Figure 2D).
Because all of these molecules are expressed on follicular T
helper (Tfh) cells, these data suggested that the transferred
T cells may attain some features of Tfh cells in the CNS andmmunity 35, 986–996, December 23, 2011 ª2011 Elsevier Inc. 987
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Figure 2. Th17 Cells Develop a Tfh Cell-like Phenotype in the CNS
Infiltrating cells were isolated from the CNS of Th17 cell recipients at the peak of disease, i.e., mice had a score of 2.5–4 for 3–7 days. Cells were directly stained
and analyzed by flow cytometry.
(A) The infiltrating cells were tested for CD4 and CD19 expression. About 30% of the infiltrating cells were T cells (range 28%–53%) and about 30% were B cells
(range 5%–32%).
(B) The infiltrating cells were tested for expression of Va3.2, which is part of the transgenic TCR expressed on transferred T cells. The vast majority of CD4+ T cells
infiltrating the CNS of Th17 cell recipients are transferred cells expressing Va3.2 (range 80%–99%).
(C) CNS T cells (left) and B cells (right) were analyzed for expression of GL7 by flow cytometry (range 15%–36% for T cells, 9%–17% for B cells).
(D) CNS-infiltrating T cells were analyzed for expression of CXCR5 (range 9%–90%), ICOS (range 40%–95%), Bcl6 (range 13%–27%), and CCR6 (range
5%–31%) by flow cytometry.
Flow cytometry data shown are representative of at least six individual mice from two or three independent in vivo experiments.
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Th17 Cells Induce Ectopic Lymphoid Folliclesprovide help to the B cells. Interestingly, the CXCR5+ T cells in
the CNS were highly enriched for IL-17+ cells (Figure S1C).
CXCR5 T cells in the CNS maintained a stable IL-17 phenotype
(Figure S1C), similar to the Th17 cell cytokine profile before
transfer (Figure S1D). In some but not all eLFs, we also detected
the GC chemokine CXCL13 decorating the collagen lining
within the CNS B cell clusters (Figure S2B). In addition to the
protein expression, we also detected significantly increased988 Immunity 35, 986–996, December 23, 2011 ª2011 Elsevier Inc.mRNA expression of CXCL13 in the spinal cords of sick Th17
cell recipients compared to spinal cords from equally sick
MOG+CFA-immunized mice or healthy naive control mice (Fig-
ure S2C). These data indicate that Th17 cells promoted the
expression of CXCL13 in the CNS, which may be responsible
for organizing eLFs. Because follicular dendritic cells (FDCs)
are a crucial component of LN follicles and GCs, we analyzed
whether any FDCswere present in the eLFs.We indeed detected
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Figure 3. Formation of Ectopic Lymphoid
Follicle-like Structures in the CNS Depends
Partly on IL-17 but Not IL-21
(A) WT, Il17ra/, and Il21r/ recipients of
different MOG-specific T cell subsets were moni-
tored for disease development. 30–40 days after
transfer, the CNS of the recipients was harvested
and analyzed for the incidence (left) and number
(right) of eLFs. Only recipients that developed
disease and survived are represented in the
graphs. For the quantification (right), only mice
with ten or more eLFs in the CNS were considered
positive and included in the analysis. Error bars
represent SEM. Graphs show combined data from
two to four independent in vivo experiments per
column.
(B and C) Th17 cells were adoptively transferred
into WT and Il17ra/ recipients (B) or into WT and
Il21r/ recipients (C) and mice were monitored
for the development of disease. Whether disease
courses were significantly different between
the groups was analyzed by linear regression
analysis (B, bottom, **p < 0.0001, and C, bottom,
*p < 0.01). Graphs in (B) show combined data from
two independent experiments (three independent
experiments were performed), and graphs in
(C) are representative of three independent
experiments.
Error bars represent SEM. Further information can
be found in Table S1.
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Th17 Cells Induce Ectopic Lymphoid FolliclesFDC-M1-positive cells in the CNS of Th17 cell recipients (Fig-
ure S3A). Of note, these cells differed from traditional FDCs in
terms of their morphology and expression of CD11b and
CD11c. Taken together, these data suggest that organized
ectopic lymphoid follicles were formed in the CNS of Th17 cell
recipients.
Th17 Cells, but Not Other Effector T Cell Subsets,
Induce Formation of eLFs
Because Th17 cells induced eLF formation upon adoptive trans-
fer, we wanted to determine whether other T cell subsets were
also able to induce ectopic lymphoid structures. We compared
the ability of various T cell subsets (Th1, Th2, Th9, and Th17),
differentiated from naive MOG-specific 2D2 TCR transgenic
T cells in vitro, to induce eLFs upon adoptive transfer. Only
one of seven sick Th1 cell recipients and none of eight sick
Th9 cell recipients formed eLFs in the CNS. Among Th2 cell
recipients, only two of six mice developedmild EAE after transfer
but did not have any eLFs. In contrast, about 73% of Th17 cell
recipients (16 of 22) formed eLFs in the CNS with an average
of 60 follicles per recipient (Figure 3A). Importantly, only Th17
cells exposed to IL-23, which maintain their IL-17-producing
phenotype upon in vivo transfer (Ja¨ger et al., 2009), inducedImmunity 35, 986–996, Dthe formation of eLFs. In contrast, Th17
cells differentiated in the presence of
TGF-b plus IL-6 and low dose of IL-2,
which do not maintain IL-17 production
but convert to IFN-g producers in vivo
(Ja¨ger et al., 2009), failed to induce eLF
formation in recipient animals. Thesedata indicate that Th17 cells, which stably produce Th17 cyto-
kines, were especially equipped to induce the formation of
eLFs, whereas other T cell subsets with the same antigen spec-
ificity, but different cytokine profile, did not induce eLF formation.
We therefore wanted to determine which Th17-specific cyto-
kines or surface molecules are responsible for Th17 cell-induced
eLF formation.
Th17 cells produce a number of effector cytokines, including
IL-17A, IL-17F, IL-21, and IL-22 (Bettelli et al., 2008), which could
potentially contribute to disease induction and eLF formation.
Among the Th17 effector cytokines, IL-17A and IL-21 have been
shown to provide B cell help and induce antibody class switching
(Doreau et al., 2009; King et al., 2008; Mitsdoerffer et al., 2010).
To address the role of IL-17 in Th17 cell-induced EAE, we trans-
ferred Th17 cells into IL-17RA-deficient mice. Interestingly,
IL-17RA-deficient mice developed attenuated EAE with signifi-
cantly lower mean maximum disease score and delayed onset
(Figure 3B; TableS1). In contrast toWTTh17cell recipients,which
often had atypical signs of EAE such as severe balance defects
and weight loss, IL-17RA-deficient animals exhibited only clas-
sical signs of EAE. In line with the clinical data, histopathologic
analysis revealed that IL-17RA-deficient mice had a slightly re-
duced number of CNS lesions and a slightly lower incidence ofecember 23, 2011 ª2011 Elsevier Inc. 989
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Figure 4. Podoplanin Is Specifically Ex-
pressed on Th17 Cells In Vitro
(A) Sorted naive CD4+ T cells were differentiated
in vitro into different T cells subsets, and after
4 days expression of Pdp was determined by flow
cytometry.
(B) Sorted naive T cells from WT or IL-17-GFP
reporter mice were differentiated in vitro with
IL-6+TGF-b. After 4 days, expression of Pdp and
IL-17-GFP was analyzed by flow cytometry.
(C) After restimulation of in-vitro-differentiated
Th1, Th2, and Th17 cells with anti-CD3 and anti-
CD28, mRNA levels of Pdp were measured at the
indicated time points.
Data shown are representative of at least three
independent experiments.
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Th17 Cells Induce Ectopic Lymphoid Folliclesrecipients developing eLFs in the CNS (55% [6 of 11] of Il17ra/
recipients versus 73% of WT recipients) (Figure 3A, left). Impor-
tantly, there was also a reduction in the number of eLFs in the
CNS of IL-17RA-deficient mice (28 ± 8 in Il17ra/ recipients
versus 60 ± 15 in WT recipients, p = 0.0813) (Figure 3A, right).
IL-21R-deficient recipients of Th17 cells developed slightly
more severe EAE with higher incidence and mortality compared
to the control group (Figure 3C; Table S1). Consistent with the
clinical data, we observed a slight increase in the number of
CNS lesions in Il21r/ recipients and a slight increase in the
percentage of recipients positive for eLFs (100%, 12 out of 12)
(Figure 3A; Table S1). There was no significant difference in the
number of eLFs found in the CNS of IL-21R-deficient recipients
(49 ± 9 in Il21r/ versus 60 ± 15 in WT recipients, p = 0.5493)
(Figure 3A).
Th17 Cells Express the Cell Surface Molecule
Podoplanin
Aside from Th17 cell-specific effector cytokines, the unique
ability of Th17 cells to form eLFs at specific anatomical sites
may also depend on cell surface molecules preferentially ex-
pressed on Th17 cells. To find potential candidates, we per-
formed gene expression profiling of T cells undergoing Th17
cell differentiation and identified two surface molecules, namely
BLT1 and Podoplanin (Pdp, gp38), which were specifically ex-
pressed under Th17 cell-polarizing conditions (Figure S4A). We
focused on the potential role of Pdp in forming eLFs. Pdp is
a type I transmembrane sialomucin-like glycoprotein, which is990 Immunity 35, 986–996, December 23, 2011 ª2011 Elsevier Inc.expressed on different epithelia,
including type I alveolar lining cells and
lymphatic endothelium (Schacht et al.,
2005); however, Pdp has not been re-
ported to be expressed on T cells. The
specific expression of Pdp and IL-17 on
T cells under Th17 cell-polarizing condi-
tions (IL-6 plus TGF-b or IL-21 plus TGF-
b) was confirmed by quantitative PCR
(Figure S4B). To test whether Pdp
expression was restricted to Th17 cells,
we differentiated sorted naive T cells
into Th0, Th1, Th2, and Th17 cells
in vitro and analyzed the different subsetsfor expression of Pdp (Figures 4A–4C). At the protein level, Pdp
was expressed on 30%–70% of cells differentiated under Th17
cell-polarizing conditions, whereas Th0, Th1, and Th2 cell popu-
lations never expressed Pdp on more than 5% of differentiated
cells (Figure 4A). Analysis of Th17 cells derived from IL-17-GFP
reporter mice showed that the majority (>70%) of IL-17-GFP+
T cells coexpressed Pdp (Figure 4B); however, 30%of T cells ex-
pressed Pdp without producing IL-17, indicating that Pdp
expression does not always correlate with IL-17 production.
Importantly, specific expression of Pdp on Th17 cells was main-
tained upon restimulation of the different T cell subsets, whereas
restimulated Th1 and Th2 cells had only low or no detectable
expression of Pdp-mRNA (Figure 4C). These data demonstrate
that Pdp is stably expressed on Th17 cells only, not on other T
helper cell subsets in vitro.
To determine whether Pdp is expressed on Th17 cells or other
hematopoietic cells in vivo, we analyzed different cell types from
LNs and spleen of naive IL-23R.GFP-KI mice for expression
of Pdp by flow cytometry (Figure S4C). In IL-23R.GFP-KI mice,
all of the IL-23R-expressing cells can be identified by GFP
expression (Awasthi et al., 2009). Interestingly, almost all
IL-23R.GFP+CD11b+CD11cint antigen-presenting cells (APCs)
and IL-23R.GFP+CD4+CD44+ memory T cells also expressed
Pdp on their surface. In addition, Pdp expression could be de-
tected on 5%–12% of gd T cells and all Pdp+ gd T cells were
also IL-23R positive. Pdp was also detected on 10%–17% of
NK cells in the LNs, whereas CD8+ T cells and B cells were nega-
tive for Pdp. Importantly, the above-described expression
Figure 3
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Figure 5. Pdp Is Expressed on Th17 Cells
In Vivo and Is Important for Formation of
the Ectopic Lymphoid Follicle-like Struc-
tures in Th17 Cell Recipients
(A–C) WT and IL-17-GFP reporter mice were
immunized with 100 mg MOG in CFA.
(A) On day 8 after immunization, splenocytes were
harvested and cultured in the presence of MOG.
After 4 days T cells were stimulated with PMA and
ionomycin in the presence of monensin for 4 hr
and analyzed for expression of IL-17-GFP and
Pdp by flow cytometry. Data shown are repre-
sentative of nine mice per group from two inde-
pendent in vivo experiments.
(B) At the peak of disease, T cells were sorted from
the CNS, spleen, and LNs and mRNA levels of
IL-17 and Pdp were determined by quantitative
PCR. Graphs are representative of two indepen-
dent in vivo experiments.
(C) At the onset of disease, infiltrating cells were
isolated frommeninges andCNS parenchyma and
expression of Pdp and IL-17-GFP on CD4+ T cells
was determined by flow cytometry directly ex vivo.
Data shown are representative of four mice per
group from two independent experiments.
(D) Th17+IL-23 cells were transferred into WT
recipients treated with 100 mg polyclonal anti-Pdp
on day 0, 2, 4, and 7 after transfer. Control animals
were treated with goat IgG or PBS. Mice were
monitored daily for development of EAE, and
30–40 days after transfer, the CNS of recipients
was harvested for histological analysis. Bar
graphs show the time of disease onset (left), the
mean maximum disease score (middle), and the
number of eLFs per recipient (right) for the anti-
Pdp-treated mice versus control mice. Graphs
show combined data from two independent
experiments. Error bars represent SEM. The
difference between the groups was tested for
significance by an unpaired Student’s t test with
Welch’s correction (*p = 0.0478) (right). Further
information can be found in Table S2.
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Th17 Cells Induce Ectopic Lymphoid Folliclespattern for Pdp was observed only in cells isolated from the LNs,
not in splenocytes, which correlates with the differential IL-23R
expression in these two compartments (Awasthi et al., 2009).
Although Pdp expression was not directly regulated by IL-23R
signaling (data not shown), it is possible that IL-23R and Pdp
expression on hematopoietic cells are partly regulated by theImmunity 35, 986–996, Dsame mechanisms, as indicated by the
fact that the majority of IL-23R+ cells
was also positive for Pdp.
To investigate whether Pdp is ex-
pressed in vivo during the development
of EAE, we first harvested LNs and spleen
from IL-17-GFP reporter or WT mice on
day 8 after immunization and analyzed
the T cells for expression of IL-17-GFP
and Pdp. Directly ex vivo, we found that
T cells from lymph node and spleen ex-
pressed IL-17-GFP, but not Pdp (Fig-
ure S5A). However, after culturing thesplenocytes with MOG for 4 days, we detected a small fraction
of IL-17-GFP+Pdp+ T cells by flow cytometry (Figure 5A). These
data indicate that in-vivo-generated Th17 cells upregulate Pdp
only when they are exposed to antigen. To pursue this hypoth-
esis further, we next isolated T cells from LNs, spleen, and
CNS at the peak of disease. Consistent with our previousecember 23, 2011 ª2011 Elsevier Inc. 991
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Th17 Cells Induce Ectopic Lymphoid Folliclesobservation, activated/memory T cells isolated from LNs or
spleen did not express Pdp-mRNA, although they produced
IL-17 (Figure 5B). In contrast, effector T cells isolated from the
CNS expressed high levels of both Pdp- and IL-17-mRNA (Fig-
ure 5B). By using IL-17-GFP reporter mice undergoing EAE, we
found that at the protein level, 80% of the IL-17-GFP+ T cells iso-
lated from the meninges coexpressed Pdp, whereas about 50%
of the IL-17-GFP+ cells isolated from the CNS parenchyma coex-
pressed Pdp (Figure 5C). However, there were also some IL-17-
GFP+ single-positive and Pdp+ single-positive cells, consistent
with the idea that not all IL-17 producers express Pdp and vice
versa (Figure 4B). In general, the fraction of Pdp+ cells was
always higher in T cells isolated from the meninges compared
to the parenchyma.
Because not only T cells but also APCs can express Pdp
in vivo, we also analyzed Pdp expression on CD11b+ cells during
EAE. On day 8 after immunization, CD11b+ cells in the LNs
expressed Pdp similar to their naive counterparts (Figure S5C).
About 1%–2% of the CD11b+ cells in the spleen—which were
completely negative for Pdp in the naive mouse—expressed
Pdp on day 8 after immunization (Figure S5C). Analogous to
the T cells, Pdp expression on CD11b+ cells was increased
during in vitro culture of splenocytes with MOG (Figure S5C).
Next, both macrophages and microglia were isolated from the
CNS and analyzed for Pdp-mRNA expression. CNS-infiltrating
macrophages and, to a lesser extent, microglia expressed
Pdp-mRNA during EAE (Figure S5B). At the protein level we
found Pdp expression on both meningeal and parenchymal
CD11b+ APCs (Figure S5C).
Together, these data show that Pdp was highly expressed on
proinflammatory cells including Th17 cells and CD11b+ cells at
the site of tissue inflammation and especially in the T cells that
form infiltrates in the meninges.
Formation of eLFs Is Partly Dependent on Pdp
Because we observed the highest expression of Pdp on Th17
cells infiltrating themeningesduringEAE,wewanted todetermine
whether Pdp plays a role in the formation of eLFs in Th17 cell
recipients. In the CNS of Th17 cell recipients, we detected Pdp
immunoreactivity around and within the eLFs, on T cells, macro-
phages, and collagen fibers (Figures S3B–S3D), indicating that
Pdp is expressed on many essential components of the eLF. In
addition, Pdp was constitutively expressed at high amounts in
the meninges, which serve as an anchor point for eLFs. To deter-
mine whether Pdp is required for eLF formation, we treated Th17
cell recipients with a Pdp blocking antibody. Anti-Pdp-treated
mice developed EAE with similar incidence and severity, but the
onset was slightly delayed when compared to either PBS- or
control-IgG-treated mice (Table S2; Figure 5D). However, histo-
logical analysis of the CNS revealed that anti-Pdp-treated mice
had significantly reduced numbers of eLFs compared goat IgG/
PBS-treated Th17 cell recipients (20 ± 2 versus 49 ± 12, *p =
0.0478) (Figure5D;TableS2), indicating thatPdp is very important
for the formation of eLFs in the CNS of Th17 cell recipients.
Pdp Is Crucial for Formation of LNs and Secondary
Lymphoid Structures
Because Pdp had a profound effect on the development of
tertiary lymphoid structures in Th17 cell recipients, we wanted992 Immunity 35, 986–996, December 23, 2011 ª2011 Elsevier Inc.to determine whether Pdp also plays a role in the development
of secondary lymphoid structures in vivo. Homozygous Pdp-
deficient mice on the original 129-Sv background die within
minutes after birth as a result of respiratory failure (Ramirez
et al., 2003; Schacht et al., 2003). However, by crossing these
mice with C57BL/6 mice, unexpectedly, some Pdp-deficient
mice survived on the mixed background and reached adult
age. Although all genotypes grossly appeared similar (Fig-
ure S6A), the peritoneal cavity and small intestine of Pdp-defi-
cient mice was ‘‘bloody’’ (Figures S6B and S6C) and the Peyer’s
patches (PP) were blood-filled and thus easily visible in Pdp-
deficient mice (Figure S6D). This is consistent with the proposed
role of Pdp in the separation of blood and lymph vessels and
thus, this ‘‘bloody’’ phenotype is caused by blood traveling
through lymphoid vessels (Uhrin et al., 2010). Intriguingly, Pdp-
deficient mice had another profound abnormality: they lacked
macroscopically visible peripheral LNs (Figure S6E). Inguinal,
brachial, axillary, and in most cases cervical LNs were absent
in Pdp-deficient mice, and in their place were small blood-filled
remnant structures (Figure S6F). Occasionally, Pdp-deficient
mice possessed one normal-sized cervical and/or a mesenteric
LN. These data indicate an important role for Pdp in the develop-
ment of peripheral LNs. In contrast to the lack of LNs, Pdp-
deficient mice had slightly enlarged spleens (Figure S6F).
Formalin-fixed, paraffin-embedded sections of LN remnants
and PP demonstrated that the structural organization with
discernible lymphoid follicles and GCs normally observed
in the WT was impaired in Pdp-deficient mice (Figure 6A);
LN remnants contained only few lymphocytes mixed with ex-
travasated blood cells. Similarly, the occasional cervical LN
completely lacked organization and GC structures but was filled
with homogeneous sheets of lymphocytes and hemosiderin,
indicating prior extravasation of blood. PP of Pdp-deficient
mice also seemed to have less conspicuous follicles compared
toWTmice (Figure 6B). To test whether there is a defect in follicle
formation in Pdp-deficient mice, we analyzed LN remnants and
spleen of Pdpn/ mice by confocal microscopy with GC-
specific markers. LN remnants of Pdp-deficient mice contained
unorganized T cells, few B cells, and hardly any GCs, which were
identified by GL7-positive staining or by an FDC-specific stain
(Figure 6C). Even in the spleens of Pdp-deficient animals, both
size and number of GCs were dramatically reduced compared
to WT littermates (Figure 6C). Within the PP, Pdp-deficient
mice had significantly more underdeveloped/incomplete follicles
containing very few or no FDCs compared to WT littermates
(data not shown). These results suggest that Pdp-deficient
mice have a major baseline defect in forming organized secon-
dary lymphoid structures and generating follicles and GCs as
observed in LNs, spleen, and PP.
DISCUSSION
Many human chronic autoimmune diseases are characterized by
the presence of ectopic follicle-like structures in the target organ,
and it has been suggested that eLFs exacerbate disease course
and propagate chronic autoimmune inflammation (Weyand
et al., 2001). We show here that Th17 cells induce formation of
eLFs in the CNS during EAE. Although other T cell subsets with
the same TCR specificity infiltrate both meninges and CNS
Figure 6. Pdp-Deficient Mice Have a Defect in the Formation of Secondary Lymphoid Structures
(A) Hematoxylin and eosin staining of paraffin sections of a LN harvested from a Pdpn+/+ mouse (left), a LN remnant harvested from a Pdpn/mouse (top right),
and a rare normal-sized LN harvested from a Pdpn/mouse (bottom right). Lymphocytes stain dark blue and extravasated red blood cells stain red (arrows, top
right).
(B) Hematoxylin and eosin staining of a paraffin section of PP harvested from Pdpn+/+ mice (left) andPdpn/mice (right). Top panels showwhole PP, and bottom
panels show one follicle of the PP.
(C) Cryosections from LNs, LN remnants, and spleens of 12-month-old Pdpn/ mice and their Pdpn+/+ littermates were analyzed for GC structure via T cell-
specific (CD3), B cell-specific (B220), and FDC-specific stains (aCR1, clone 8C12), as well as the GC marker GL7 and the structural marker collagen.
Data shown are representative of three independent experiments. Scale bars in (A) (top) and (B) (bottom) represent 50 mm. Scale bars in (A) (bottom) and (B) (top)
represent 100 mm. Scale bar in (C) represents 200 mm.
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Th17 Cells Induce Ectopic Lymphoid Folliclesparenchyma and induce clinical signs of EAE, they fail to induce
formation of eLFs. Immunohistochemical characterization
showed that the eLFs in the CNS of Th17 cell recipients dis-
played a wide range in their degree of maturation: although
some merely constituted B cell aggregates, the majority of the
B cell clusters were very structured and encapsulated by reticu-
lin fibers. We found evidence that GC-like reactions are ongoing
in some but not all of the eLFs, as suggested by the presence ofICXCL13, PNA- andGL7-positive T and B cells, and plasma cells.
In addition, we detected expression of the Tfh cell-associated
molecules CXCR5, ICOS, and Bcl6 on the CNS T cells, indicating
that the transferred Th17 cells may fulfill tasks of Tfh cells that are
essential for the GC reaction (Mitsdoerffer et al., 2010). In
support of this hypothesis, IL-21R-deficient recipients of Th17
cells also developed eLFs in the CNS despite their lack of endog-
enous Tfh cells, which require IL-21 as an autocrine growth andmmunity 35, 986–996, December 23, 2011 ª2011 Elsevier Inc. 993
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Th17 Cells Induce Ectopic Lymphoid Folliclesdifferentiating factor (Vogelzang et al., 2008). Our transfer exper-
iments with IL-21R-deficient recipients suggest that IL-21R
signaling in host cells (but not transferred Th17 cells) may be
dispensable for disease induction and eLF formation by Th17
cells. Because IL-21 is known to promote B cell differentiation
and isotype switching (Spolski and Leonard, 2008), this result
was surprising. However, besides acting as an amplification
factor for Th17 and Tfh cells (Vogelzang et al., 2008; Korn
et al., 2007), IL-21 also induces IL-10-producing Tr1 cells (Pot
et al., 2009), which are known to limit tissue inflammation in
autoimmune diseases (Fitzgerald et al., 2007). Therefore, the
increased disease severity in IL-21R-deficient mice may be
due to a defect in generating regulatory Tr1 cells and thus
controlling Th17 cell-induced tissue inflammation.
Our transfer experiments with IL-17RA-deficient recipients
showed that IL-17 contributes to disease severity and may be
responsible for the development of atypical signs of EAE.
Previous studies have associated atypical signs of EAE with
lesions in the brainstem and cerebellum, which appear to be
especially sensitive to IL-17-mediated inflammation but pro-
tected by the Th1 cytokine IFN-g (Lees et al., 2008; Stromnes
et al., 2008). Notably, our data also suggest that IL-17 itself
may contribute to eLF formation, which is consistent with
a recent report showing that IL-17 and Th17 cells promote the
spontaneous formation of GCs in the spleen of autoimmune-
prone BXD2 mice (Hsu et al., 2008).
Aside from specific cytokines like IL-17, Th17 cells may also
rely on specialized surface molecules to promote eLF forma-
tion, which could explain why eLFs always appear at defined
anatomical sites. Podoplanin is specifically expressed on Th17
cells in vitro, but in-vivo-generated Th17 cells express Pdp
only upon reactivation with antigen in a recall assay or once
they enter the CNS, suggesting that Pdp is important for Th17
effector cell functions in the target organ. Pdp appears to play
an important role in the process of eLF formation, because
blocking of Pdp in vivo significantly reduced the number of
eLFs in the CNS of Th17 cell recipients. It is possible that—owing
to their expression of Pdp—Th17 cells can attach themselves
better to the meninges than other T cell subsets and thus
promote eLF formation in the subarachnoid space. Whether
the blocking of Pdp on Th17 cells themselves or on other cell
types (macrophages, stromal, and parenchymal cells) leads to
the reduction in eLFs in vivo remains to be determined. Never-
theless, our data underscore the role of Pdp in forming eLFs
during an autoimmune reaction. Notably, Pdp expression on
parenchymal tissue and macrophages was observed not only
in Th17 cell recipients, but also in Th1 cell recipients (data not
shown), suggesting that expression of Pdp on stromal or tissue
cells andmacrophages alonemay not be sufficient for the forma-
tion of eLFs in the CNS.
It is interesting that the reduction of eLFs observed in anti-
Pdp-treated Th17 cell recipients did not result in diminution of
clinical disease, which may lead to the conclusion that eLFs do
not contribute to clinical disease in EAE, contrary to a previous
report (Columba-Cabezas et al., 2006). However, it is more likely
that the clinical effects of eLF formation cannot be observed in
such a short acute disease model, in which the clinical signs
are also due to other pathological processes, including edema,
inflammation, and demyelination in the CNS. Clinical effects of994 Immunity 35, 986–996, December 23, 2011 ª2011 Elsevier Inc.eLFs might be more apparent in a chronic disease model that
resembles chronic progressive disease in MS—in which eLFs
are most often observed (Magliozzi et al., 2007; Serafini et al.,
2004).
The defects we described in the development of secondary
lymphoid structures of Pdp-deficient mice further emphasize
the importance of Pdp for the proper organization and formation
of lymphoid structures. However, we want to point out that the
observed defects in the development of secondary lymphoid
organs are due not simply to Pdp-deficient T cells, but also to
impaired development and/or function of several different cell
types including FDCs and stromal cells—especially fibroblastic
reticular cells (FRCs) and lymphoid endothelial cells—which all
express Pdp (Hirakawa et al., 2003; Schacht et al., 2005). In addi-
tion, it has been shown that Pdp deficiency leads to formation of
inadequately functioning lymphatic vessels (Schacht et al., 2003;
Uhrin et al., 2010), which may also contribute to the observed
defects within the secondary lymphoid structures. The mecha-
nism by which Pdp promotes formation of lymphoid structures
is not clear. CLEC-2, a C-type lectin-like receptor expressed
on platelets (Suzuki-Inoue et al., 2006), neutrophils (Kerrigan
et al., 2009), and DCs (Colonna et al., 2000), has been identified
as a ligand for Pdp (Suzuki-Inoue et al., 2007). Thus, formation of
secondary and tertiary lymphoid structures might be enhanced
by interaction of Pdp on stromal cells and T cells with CLEC-2
on DCs.
Taken together, we propose that the specific expression of
Pdp on Th17 cells together with the presence of Th17-specific
cytokines like IL-17 may act in concert to promote the formation
of eLFs in the CNS. Because Pdp is crucial during development
for the formation of LNs and other secondary lymphoid struc-
tures, it is tempting to speculate that Pdp is coopted by Th17
cells to form tertiary lymphoid structures in the target tissues
during autoimmune inflammation. Therefore, IL-17 and Pdp
may provide important targets in regulating tissue inflammation
where ectopic lymphoid follicles play an important role in propa-
gation of autoimmune diseases.
EXPERIMENTAL PROCEDURES
Animals
2D2 mice (Bettelli et al., 2003) and IL-23R.GFP-KI mice (Awasthi et al., 2009)
were described previously. Il21r/ mice (Kasaian et al., 2002) were provided
by M. Grusby (Harvard School of Public Health, Boston, MA), Il17ra/ mice
(Ye et al., 2001) by J. Kolls (LSU Health Science Center, New Orleans, LA),
and Pdpn/mice on 129Sv background (Ramirez et al., 2003) by M. Ramirez
(Boston University, Boston, MA). IL-17A-GFP reporter mice were generated
and provided by Y. Shen (Biocytogen, Worcester, MA). Mice were housed in
a specific-pathogen-free, viral-antibody-free animal facility at the Harvard
Institutes of Medicine. All breeding and experiments were reviewed and
approved by the Institutional Animal Care and Use Committee of Harvard
Medical School.
Induction and Assessment of EAE
Differentiation of naive MOG-specific T cells into different subsets followed
by adoptive transfer into C57BL/6 recipient mice for the induction of EAE
was performed as described previously (Ja¨ger et al., 2009; see also http://
kuchroo-lab.bwh.harvard.edu/Kuchroo FrequentlyRequestedProtocols.htm).
In brief, sorted naive T cells from 2D2 mice were differentiated into different
T cell subsets in vitro and tested for cytokine production after 4 days. After
6–7 days, cells were restimulated in vitro with CD3 and CD28 antibodies for
48 hr. 2.5–3 3 106 cytokine-producing cells were injected intravenously into
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Th17 Cells Induce Ectopic Lymphoid FolliclesC57BL/6 recipients. For antibody treatment of Th17 cell recipients, mice were
injected intravenously with 100 mg polyclonal anti-murine Podoplanin antibody
or 100mgNormalGoat IgG (R&DSystems,Minneapolis,MN)orPBSonday0, 2,
4, and 7 after Th17 cell transfer.
Induction of EAE by immunization withMOG inCFA, recall assays, and isola-
tion of cells from the CNS were performed as described previously (Awasthi
et al., 2009; Ja¨ger et al., 2009).
Animals were monitored daily for the development of classical and atypical
signs of EAE according to the following criteria: 0, no disease; 1, decreased tail
tone or mild balance defects; 2, hind limb weakness, partial paralysis, or
severe balance defects that cause spontaneous falling over; 3, complete
hind limb paralysis or very severe balance defects that prevent walking; 4, front
and hind limb paralysis or inability to move body weight into a different posi-
tion; 5, moribund state.
Histology and Immunohistochemistry
CNS, LNs, spleen, and PP were formalin fixed and paraffin embedded and
slides were analyzed after Luxol fast blue-hematoxylin and eosin stains,
silver stain, or incubation with Podoplanin antibody (8.1.1)/Syrian Hamster
IgG isotype control (SHG-1) (BioLegend). For immunohistochemistry of LNs,
LN remnants, spleen, and PP were snap-frozen in OCT medium and cut in
8 mm sections. For immunohistochemistry of the CNS, mice were perfused
30–40 days after Th17 cell transfer with 4% paraformaldehyde. CNS was
dehydrated in 30%sucrose for 24 hr and frozen in OCTmedium. 8 mmsections
were fixed in acetone, incubated with anti-FcR (2.4G2), and stained with
the following antibodies in PBS containing 1% bovine serum albumin
and 0.1% saponin for collagen stainings: aCD4-FITC and APC (RM4-5),
aPdp-A488 and biotinylated (8.1.1), syrian hamster IgG isotype control
(SHG-1), aCD11b-APC and PE (M1/70), Armenian hamster aCD11c (N418),
aB220-APC (RA3-6B2) (all fromBioLegend); rabbit a-typeI-collagen (Rockland
Immunochemicals); biotinylated aB220 (RA3-6B2), Armenian hamster aCD3
(145-2C11), aCD35-A488 (8C12), FDC-M1-A488, (all produced and labeled
in house); aCD138-PE or biotinylated (281-2), GL7-FITC, Streptavidin-PE
(all from BD PharMingen); biotinylated aCXCL13, (from R&D Systems);
Streptavidin-A633 and A488, a-rabbit-A568 and A633, goat a-rat-A488
(all from Invitrogen); a-Armenian hamster-DyLight488 and Cy3 (Jackson
ImmunoResearch). Images were acquired on a Zeiss-BioRad Radiance
2000 MP confocal microscope.
Quantification of Lymphoid Aggregates
Lymphoid follicle-like aggregateswere counted in Luxol fast blue-H&E-stained
paraffin sections of the entire CNS of each mouse by a neuropathologist who
was blinded to the clinical, genotype, and treatment parameters. Each sample
counted contained representative 8 mm thick sections of 5 levels of brain tissue
and 15–20 sections of spinal cord tissue. Thus, both the sampling and total
areas of CNS tissue analyzed were uniform for each mouse. Leptomeningeal
lymphoid infiltrates were frequently confluent but were counted as individual
lymphoid follicles when there were round or ovoid aggregates with at least
five mononuclear cell layers. Some aggregates showed central GCs in the
routine sections, but most aggregates were small and round (i.e., mature-
appearing lymphoid cells).
Flow Cytometry
The following antibodies were used for flow cytometry: aCD4-PerCP or PE or
PECy7 or Pacific Blue (RM4-5), aCD62L-PE (MEL-14), aCD44-PE (IM7), aIFN-
g-PE (XMG1.2), aIL-17-APC or PE (TC11-18H10.1), aIL-10-PE (JES5-10E3),
aCD11b-Pacific Blue or APC (M1/70), aCD11c-PE or PECy7 (N418), aCD19-
APCCy7 or PE or PECy7 (6D5), aICOS-PE or PECy7 (7E.17G9), aNK1.1-APC
(PK136), a-mouse IgD-PE (11-26C.2a), aPdp-FITC or biotinylated (8.1.1),
and the corresponding isotype control Syrian hamster IgG (SHG-1), rat
IgG2a-PE or APC isotype control (RTK2758), mouse IgG1-PE isotype control
(MOPC-21), Armenian hamster IgG-PE or PECy7 isotype control (HTK888),
and Streptavidin-APC were all purchased from BioLegend. aCD8-PECy7
(53-6.7), aIL-17F-A647 (eBio18F10), and a-gd-TCR-PE (eBioGL3) were
purchased from eBioscience (San Diego, CA, USA). aVa3.2 TCR-biotin or
FITC (RR3-16), aCD3-APC-Cy7 (1452C11), GL7-FITC, aCXCR5-PE (2G8),
aCCR6-A647 (140706), aCD138-APC (281-2), a-mouse IgM-biotin (II/41),
a-mouse IgG1-PE (A85-1), rat IgM-FITC isotype control (R4-22), and aBcl6-IPE (K112-91) were all purchased from BD PharMingen (San Diego, CA,
USA). a-mouse IgG2a-PE (SB84A), a-mouse IgG2b-PE, and a-mouse
IgG3-PE (LO-MG3) were purchased from Southern Biotech (Birmingham,
AL, USA). Biotinylated a-PNA was purchased from Vector Laboratories
(Burlingame, CA, USA).
All flow cytometry data were acquired on a BD FACSCalibur or BD LSRII and
analyzed with FlowJo Tree Star software.
Quantitative PCR
RNA was extracted from cells with the RNeasy Kit (QIAGEN) according to the
manufacturer’s instructions. For extraction of total RNA from the spinal cord,
mice were perfused with PBS and spinal cords were homogenized in TRIzol
Reagent (Ambion). RNA was isolated according to the manufacturer’s instruc-
tions, treated with the RNase-Free DNase Set (QIAGEN) to remove low-level
DNA contamination, and purified via the RNA Cleanup protocol (QIAGEN).
1–2 mg RNA was then transcribed into cDNA with the iScript cDNA Synthesis
Kit (BIO-RAD) according to the manufacturer’s instructions. Quantitative PCR
primers and probes were purchased from Applied Biosystems (IL-17A,
Mm00439619_m1; Pdp, Mm00494716_m1; CXCL13, Mm00444534_m1;
b-Actin, 4352341E).
Statistics
All error bars shown represent SEM. For the quantification of eLFs shown in
Figures 3A (right) and 5D (right), only mice with ten or more eLFs were included
in the analysis. Whether differences between groups are significant was deter-
mined with an unpaired Student’s t test with a Welch’s correction because the
variances within the groups were significantly different. In Figures 3B and 3C,
a linear regression analysis was performed to determine whether the differ-
ences between the groups are significant. All other data including data shown
in Tables S1 and S2, Figure S2C, and Figure 5D (left) were tested for significant
differences by an unpaired Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and two tables and can be
found with this article online at doi:10.1016/j.immuni.2011.10.015.
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